Ignite Creation Date:
2024-05-06 @ 6:36 PM
Last Modification Date:
2024-10-26 @ 2:51 PM
Study NCT ID:
NCT05722977
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-02-10
First Post:
2023-02-01
Brief Title:
Surufatinib and Envafolimab as Second or More-line Therapy in Advanced Soft Tissue Sarcoma Patients
Sponsor:
Peking Union Medical College Hospital
Organization:
Peking Union Medical College Hospital
Organization Data
Organization:
Peking Union Medical College Hospital
Class:
OTHER
Study ID:
Slufenvo
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Peking Union Medical College Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
WangXiang
Responsible Party Title:
chief physician
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Peking Union Medical College Hospital
Old Name:
None
Old Organization:
None